Schonfeld Strategic Advisors LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$73,470
+120.2%
23,700
-1.2%
0.00%
Q1 2023$33,360
-42.0%
24,000
-17.0%
0.00%
Q4 2022$57,511
-11.5%
28,900
-10.7%
0.00%
-100.0%
Q3 2022$65,000
-84.3%
32,352
-47.5%
0.00%
-80.0%
Q1 2021$414,000
+163.7%
61,567
+78.5%
0.01%
+150.0%
Q4 2020$157,000
-96.3%
34,500
-81.7%
0.00%
-98.9%
Q3 2018$4,187,000
+305.7%
188,700
+200.1%
0.19%
+232.1%
Q2 2018$1,032,00062,8720.06%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders